Methamphetamine (MA) related overdose deaths have increased dramatically in the United States in the past several years. MA use is linked to a variety of adverse health related conditions and can complicate the management of chronic and infectious disease and severely impact one’s overall quality of life. There are currently no FDA approved medications for the treatment of Methamphetamine Use Disorder and there are a limited number of effective behavioral treatment options. Researchers at UCLA, including CBAM’s own Dr. Joy Chudzysnki, found that exercise significantly reduced craving in a sample of participants enrolled in a residential treatment program for methamphetamine use. Those participants reporting less craving during treatment had less MA use after discharge, suggesting that incorporation of a structured exercise program for individuals with MA-use disorder into existing treatment programs may improve outcomes.

Click here to read the paper in its entirety.


CBAM is a multidisciplinary center that seeks to advance the prevention and treatment of chronic illnesses, especially in communities with health disparities. As part of the UCLA Department of Family Medicine, CBAM works at the intersection of academia and community with a focus on treating addictions and preventing the spread of HIV.

© The UCLA Center for Behavioral & Addiction Medicine (CBAM). All Rights Reserved.